2004
DOI: 10.1007/s11910-004-0039-z
|View full text |Cite
|
Sign up to set email alerts
|

Leptomeningeal metastases

Abstract: Leptomeningeal metastasis, also known as neoplastic meningitis, carcinomatous meningitis, and meningeal carcinomatosis, occurs when cancer cells gain access to cerebrospinal fluid pathways, travel to multiple sites within the central nervous system, settle, and grow. This disease has become an increasingly important late complication in oncology as patients survive longer, develop more brain metastases, and newer chemotherapies fail to penetrate the blood-brain barrier. The hallmark of clinical presentation is… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
30
0
1

Year Published

2004
2004
2016
2016

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 46 publications
(31 citation statements)
references
References 53 publications
0
30
0
1
Order By: Relevance
“…analysis. A number of different biological markers such as lactate dehydrogenase (LDH) and b-glucuronidase have been proposed (2). However, the lack of sensitivity and specificity of these analytes limits their use in diagnostic practice.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…analysis. A number of different biological markers such as lactate dehydrogenase (LDH) and b-glucuronidase have been proposed (2). However, the lack of sensitivity and specificity of these analytes limits their use in diagnostic practice.…”
Section: Discussionmentioning
confidence: 99%
“…According to autopsy studies, LM occurs in 5%-8% of cancer cases. However, the incidence is increasing and is probably due to more effective therapies and better diagnostic tools (1,2). Although LM is a late complication in most patients, in 5%-10% it is the first manifestation of cancer (3).…”
Section: Introductionmentioning
confidence: 99%
“…As a result, micrometastases grow and become clinically evident months to years later, while the systemic disease continues in remission [3]. Therefore, although most leptomeningeal metastases occur in widely disseminated and progressive systemic cancer [4], it is not unusual that leptomeningeal metastases cause neurological function impairment in a cancer patient, particularly from breast carcinoma, which is found to have multifocal signs on the neurological examination and has no evidence of systemic disease [5].…”
Section: Leptomeningeal Metastasesmentioning
confidence: 99%
“…(14) Small cell lung cancer and myeloblastic leukaemia are more likely to spread to meninges. (15) Neurolymphomatosis (NL) (16) seen in three of our patients is characterized by infiltration of malignant lymphocytes into the peripheral nervous system particularly the cranial nerves, spinal nerve roots, brachial/lumbar plexus, and/or peripheral nerves. It is a rare neurological manifestation (0.8-2.5%).…”
Section: Localization Of Lesion In the Nervesmentioning
confidence: 96%